buserelin has been researched along with Lupus Erythematosus, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichijo, M; Miyagawa, S; Shimamoto, I; Shirai, T; Ueki, H | 1 |
| Ansari, MA; Jacobson, JD; Kinealy, M; Muthukrishnan, V | 1 |
| Catania, A; Mangone, I; Motta, P; Zanussi, C | 1 |
3 other study(ies) available for buserelin and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Worsening of systemic lupus erythematosus-associated thrombocytopenia after administration of gonadotropin-releasing hormone analog.
Topics: Adult; Buserelin; Female; Humans; Lupus Erythematosus, Systemic; Thrombocytopenia | 1994 |
Gender-specific exacerbation of murine lupus by gonadotropin-releasing hormone: potential role of G alpha(q/11).
Topics: Animals; Buserelin; Estradiol; Female; Gene Expression Regulation; Gonadotropin-Releasing Hormone; GTP-Binding Proteins; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred Strains; Orchiectomy; Ovariectomy; Receptors, Interleukin-2; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sex Characteristics; Testosterone; Time Factors; Transcription, Genetic | 1999 |
Administration of gonadotropin-releasing hormone analog as adjunctive therapy in women with systemic lupus erythematosus.
Topics: Adolescent; Adult; Buserelin; Drug Evaluation; Female; Humans; Lupus Erythematosus, Systemic; Time Factors | 1989 |